1.8700
+0.0300
+(1.63%)
At close: 4:00:00 PM EDT
2.2000
+0.33
+(17.65%)
After hours: 6:05:03 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Justin J. File CPA | Acting CEO, CFO & Corporate Secretary | 614.7k | -- | 1970 |
| Ms. Yomara Gomez-Naiden | Senior Vice President of Operations & Quality | -- | -- | -- |
| Ms. Nicole Chyoko Iida | Vice President of Legal Affairs | -- | -- | -- |
| Ms. Anne Frese | Chief People Officer | -- | -- | -- |
| Dr. Robert D. Mass | Strategic Advisor | 201.68k | -- | 1954 |
| Mr. David A. Walsey J.D., L.L.M. | Senior Vice President of Corporate Affairs | -- | -- | -- |
MEI Pharma, Inc.
9920 Pacific Heights Blvd.
Suite 150
San Diego, CA 92121
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 28
Description
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
Corporate Governance
MEI Pharma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
MEI Pharma, Inc. Earnings Date
Recent Events
Related Tickers
KANT Kineta, Inc.
0.2940
0.00%
GKO.BE GlycoMimetics Inc
0.1684
-0.71%
2181.HK Mabpharm Limited
0.490
-1.01%
CASI CASI Pharmaceuticals, Inc.
1.9500
+2.09%
9966.HK Alphamab Oncology
6.370
+7.42%
RSPI RespireRx Pharmaceuticals Inc.
0.0008
0.00%
APLM Apollomics, Inc.
5.95
+3.93%
MAZE Maze Therapeutics, Inc.
7.83
+3.03%
IPSC Century Therapeutics, Inc.
0.4800
+17.70%
PVLA Palvella Therapeutics, Inc.
21.76
+9.51%